Collectively, these elements are supporting the market's robust and long-term growth trajectory
In the UK, the regulatory pathway for new medicines requires the MHRA to assess comprehensive evidence of safety, efficacy, and quality before granting a marketing authorisation
And if you are prescribed a GLP-1, don't expect to be given a patch anytime soon
The trial results showed that after a 68-week treatment period, the oral semaglutide group achieved a significant weight reduction compared to the placebo group, with a 17.4% decrease in body weight versus 1.8% in the placebo group
Check our tirzepatide dosing guide in units for the exact syringe markings at each dose level
Profile 5: Chronic Pancreatitis or a History of Acute Pancreatitis The FDA prescribing information for semaglutide notes that GLP-1 receptor agonists have been associated with acute pancreatitis, including fatal cases [3]